Section |
Status |
NHS England |
Name |
08.01.05 |
Formulary
|
|
Abemaciclib Verzenios® |
08.01.05 |
Formulary
|
|
Acalabrutinib Calquence® |
08.01.05 |
Formulary
|
|
Afatinib Giotrif® |
08.01.05 |
Formulary
|
|
Alectinib Alecensa® |
10.01.03 |
Restricted Use
|
|
Anakinra Kineret® |
08.01.05 |
Formulary
|
|
Arsenic Trioxide Trisenox® |
09.08.01 |
Restricted Use
|
|
Asfotase alfa |
08.01.05 |
Formulary
|
|
Autologous anti-CD19-transduced CD3+ cells |
08.02.03 |
Formulary
|
|
Avelumab Bavencio® |
10.01.03 |
Restricted Use
|
|
Avelumab Bavencio® |
08.02.04 |
Formulary
|
|
Axicabtagene ciloleucel Yescarta® |
08.01.03 |
Formulary
|
|
Azacitidine Vidaza® |
08.01.01 |
Formulary
|
|
Bendamustine |
03.04.02 |
Formulary
|
|
Benralizumab |
03.14 |
Formulary
|
|
Benralizumab Fasenra® |
03.04.03 |
Formulary
|
|
Berotralstat Orladeyo® |
08.01.02 |
Formulary
|
|
Bleomycin |
08.02.03 |
Formulary
|
|
Blinatumomab Blincyto® |
08.01.05 |
Formulary
|
|
Brentuximab vedotin Adcetris® |
08.01.05 |
Formulary
|
|
Brigatinib Alunbrig® |
08.01.01 |
Formulary
|
|
Busulfan |
03.04.03 |
Formulary
|
|
C1- esterase Inhibitor Berinert® |
03.04.03 |
Formulary
|
|
C1- esterase Inhibitor Cinryze® |
08.01.05 |
Formulary
|
|
Cabozantinib Cabometyx® |
04.08.01 |
Formulary
|
|
Cannabidiol Epidyolex® |
08.01.03 |
Formulary
|
|
Capecitabine |
09.01.04 |
Formulary
|
|
Caplacizumab Cablivi® |
08.01.05 |
Restricted Use
|
|
Carfilzomib Kyprolis® |
08.01.01 |
Formulary
|
|
Carmustine Gliadel® |
08.01.05 |
Formulary
|
|
Cemiplimab Libtayo® |
08.01.05 |
Formulary
|
|
Cenegermin Oxervate® |
08.01.05 |
Formulary
|
|
Ceritinib Zykadia® |
08.01.01 |
Formulary
|
|
Chlorambucil |
08.01.05 |
Formulary
|
|
Chlormethine gel Ledaga® |
09.05.01.02 |
Formulary
|
|
Cinacalcet Mimpara® |
08.02.04 |
Formulary
|
|
Cladribine Mavenclad® |
12.01.01 |
Formulary
|
|
Cochlear implants |
03.13 |
Formulary
|
|
Colistimethate sodium |
03.04.03 |
Formulary
|
|
Conestat Alfa Ruconest® |
08.01.05 |
Formulary
|
|
Crizotinib Xalkori® |
08.01.01 |
Formulary
|
|
Cyclophosphamide |
08.01.03 |
Formulary
|
|
Cytarabine-Daunorubicin Liposomal Vyxeus® |
08.01.05 |
Formulary
|
|
Dabrafenib with trametinib |
08.01.05 |
Formulary
|
|
Dacomitinib Vizimpro® |
08.01.02 |
Formulary
|
|
Dactinomycin |
08.01.05 |
Formulary
|
|
Daratumumab Darzalex® |
08.03.04.02 |
Formulary
|
|
Darolutamide Nubeqa® |
08.01.02 |
Formulary
|
|
Daunorubicin |
08.02.04 |
Formulary
|
|
Dimethyl fumarate Tecfidera® |
08.02.03 |
Formulary
|
|
Dinutuximab Qarziba® |
08.01.05 |
Restricted Use
|
|
Docetaxel Taxotere® |
03.07 |
Formulary
|
|
Dornase Alfa Pulmozyme® |
08.01.05 |
Formulary
|
|
Dostarlimab Jemperli® |
08.01.02 |
Formulary
|
|
Doxorubicin Hydrochloride Myocet® |
08.01.02 |
Formulary
|
|
Doxorubicin Hydrochloride |
08.01.05 |
Formulary
|
|
Durvalumab Imfinzi® |
08.01.05 |
Formulary
|
|
Encorafenib plus cetuximab Braftovi® + Erbitux® |
08.01.05 |
Formulary
|
|
Encorafenib with binimetinib Braftovi® + Mektovi ® |
08.01.05 |
Formulary
|
|
Entrectinib Rozlytrek® |
08.03.04.02 |
Restricted Use
|
|
Enzalutamide Xtandi® |
08.01.02 |
Formulary
|
|
Epirubicin hydrochloride |
08.01.05 |
Formulary
|
|
Eribulin Halaven® |
08.01.05 |
Formulary
|
|
Erlotinib Tarceva® |
08.01.01 |
Formulary
|
|
Estramustine phosphate Estracyt® |
09.05.01.02 |
Formulary
|
|
Etelcalcetide Parsabiv® |
08.01.05 |
Formulary
|
|
Everolimus Afinitor® |
08.01.03 |
Formulary
|
|
Fludarabine Phosphate |
08.01.03 |
Formulary
|
|
Gemcitabine Gemzar® |
08.02.03 |
Formulary
|
|
Gemtuzumab ozogamicin Mylotarg® |
08.01.05 |
Formulary
|
|
Gilteritinib Xospata® |
05.03.03.02 |
Formulary
|
|
Glecaprevir-pibrentasvir Maviret® |
08.01.05 |
Formulary
|
|
Hydroxycarbamide |
08.01.05 |
Formulary
|
|
Ibrutinib Imbruvica® |
03.04.03 |
Restricted Use
|
|
Icatibant Firazyr® |
08.01.02 |
Formulary
|
|
Idarubicin Hydrochloride |
08.01.05 |
Formulary
|
|
Idelalisib Zydelig® |
08.01.01 |
Formulary
|
|
Ifosfamide |
02.05.01 |
Formulary
|
|
Iloprost nebules Vantavis® |
08.02.03 |
Formulary
|
|
Inotuzumab ozogamicin Besponsa® |
08.01.05 |
Formulary
|
|
Isatuximab |
08.01.05 |
Restricted Use
|
|
Ixazomib |
08.01.05 |
Formulary
|
|
Ixazomib Ninlaro® |
03.04.03 |
Formulary
|
|
Lanadelumab Takhzyro® |
08.01.05 |
Formulary
|
|
Larotrectinib Vitrakvi® |
08.02.04 |
Restricted Use
|
|
Lenalidomide |
08.01.05 |
Formulary
|
|
Lenvatinib Kisplyx® |
05.03.02.02 |
Formulary
|
|
Letermovir Prevymis® |
08.01.01 |
Formulary
|
|
Lomustine |
08.01.05 |
Formulary
|
|
Lorlatinib Lorviqua® |
08.03.04.03 |
Formulary
|
|
Lutetium (177Lu) oxodotreotide Lutathera® |
02.05 |
Formulary
|
|
Macitentan Opsumit® |
03.07 |
Restricted Use
|
|
Mannitol Bronchitol® |
06.07 |
Non Formulary
|
|
Mecasermin Increlex® |
08.01.01 |
Formulary
|
|
Melphalan |
03.14 |
Formulary
|
|
Mepolizumab Nucala® |
08.01.03 |
Formulary
|
|
Methotrexate |
08.01.05 |
Formulary
|
|
Midostaurin Rydapt® |
08.01.02 |
Formulary
|
|
Mitomycin |
08.01.02 |
Formulary
|
|
Mitoxantrone |
08.01.05 |
Formulary
|
|
Neratinib Nerlynx® |
03.11 |
Restricted Use
|
|
Nintedanib Ofev® |
03.11 |
Formulary
|
|
Nintedanib Vargatef® |
08.01.05 |
Formulary
|
|
Niraparib Zejula® |
08.02.03 |
Formulary
|
|
Nivolumab Opdivo® |
10.02 |
Formulary
|
|
Nusinersen Spinraza® |
08.02.03 |
Formulary
|
|
Obinutuzumab Gazyvaro® |
08.02.03 |
Formulary
|
|
Ocrelizumab Ocrevus® |
08.02.03 |
Formulary
|
|
Ofatumumab Arzerra® |
08.01.05 |
Formulary
|
|
Olaparib Lynparza® |
03.04.02 |
Restricted Use
|
|
Omalizumab Xolair® |
08.01.05 |
Formulary
|
|
Osimertinib |
08.01.05 |
Restricted Use
|
|
Paclitaxel albumin-bound Abraxane® |
08.01.05 |
Formulary
|
|
Palbociclib Ibrance® |
08.01.05 |
Formulary
|
|
Pegaspargase Oncaspar® |
08.01.05 |
Formulary
|
|
Pegcetacoplan Aspaveli® |
08.02.04 |
Formulary
|
|
Peginterferon beta-1a Plegridy® |
08.01.05 |
Formulary
|
|
Pemigatinib Pemazyre® |
08.01.05 |
Formulary
|
|
Pertuzumab Perjeta® |
03.11 |
Restricted Use
|
|
Pirfenidone Esbriet® |
08.01.05 |
Formulary
|
|
Polatuzumab Polivy® |
08.01.05 |
Formulary
|
|
Ponatinib Iclusig® |
08.02.04 |
Formulary
|
|
Ponesimod Ponvory® |
03.05.02 |
Restricted Use
|
|
Poractant Alfa Curosurf® |
08.01.03 |
Formulary
|
|
Raltitrexed Tomudex® |
09.01.03 |
Formulary
|
|
Ravulizumab Ultomiris® |
08.01.05 |
Formulary
|
|
Regorafenib Stivarga® |
08.01.05 |
Formulary
|
|
Ribociclib Kisqali® |
08.02.03 |
Formulary
|
|
Rituximab MabThera® |
08.01.05 |
Formulary
|
|
Rucaparib Rubraca® |
08.01.05 |
Formulary
|
|
Ruloxitinib Jakavi® |
08.04 |
Formulary
|
|
Selective internal radiation therapies |
08.01.05 |
Formulary
|
|
Selpercatinib Retsevmo® |
08.02.04 |
Formulary
|
|
Siponimod Mayzent® |
05.03.03.02 |
Formulary
|
|
Sofosbuvir/Velpatasvir/Voxilaprevir Vosevi® |
08.01.05 |
Formulary
|
|
Sotorasib Lumykras® |
09.05.02.02 |
Formulary
|
|
Sucroferric oxyhydroxide Velphoro® |
08.01.05 |
Formulary
|
|
Sunitinib Sutent® |
08.01.05 |
Formulary
|
|
Talimogene Iaherparepvec Imlygic® |
08.01.05 |
Formulary
|
|
Tepotinib Tepmetko® |
08.02.04 |
Restricted Use
|
|
Teriflunomide Aubagio® |
08.02.04 |
Formulary
|
|
Thalidomide |
13.05.03 |
Formulary
|
|
Thalidomide |
08.01.01 |
Formulary
|
|
Thiotepa |
08.01.03 |
Formulary
|
|
Tioguanine |
08.01.05 |
Formulary
|
|
Tisagenlecleucel Kymriah® |
08.01.05 |
Formulary
|
|
Tivozanib Fotivda® |
10.01.03 |
Restricted Use
|
|
Tocilizumab RoActemra® |
08.01.05 |
Formulary
|
|
Trastuzumab Enhertu® |
08.01.05 |
Formulary
|
|
Trastuzumab emtansine Kadcyla® |
08.01.01 |
Formulary
|
|
Treosulfan |
08.01.03 |
Formulary
|
|
Trifluridine-tipiracil Lonsurf® |
08.01.05 |
Formulary
|
|
Tucatinib Tukysa® |
08.01.05 |
Formulary
|
|
Vemurafenib Zelboraf® |
08.01.05 |
Formulary
|
|
Venetoclax Venclyxto® |
08.01.04 |
Formulary
|
|
Vinorelbine |